Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial - Wikidata - wikimedia - TriplyDB

Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial

Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial

http://www.wikidata.org/entity/Q34527061

about

Drug interventions for the treatment of obesity in children and adolescents Metformin in obesity, cancer and aging: addressing controversies Metformin use in children with obesity and normal glucose tolerance--effects on cardiovascular markers and intrahepatic fat.Commentary: A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin Treatment of Weight Gain Associated with Initiation of Atypical Antipsychotic Therapy in Children and Adolescents Obese and overweight children and adolescents: an algorithmic clinical approach.Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome.Addressing prediabetes in childhood obesity treatment programs: support from research and current practice.An evolving scientific basis for the prevention and treatment of pediatric obesity Unplanned medication discontinuation as a potential pharmacovigilance signal: a nested young person cohort study Effects of metformin on energy intake and satiety in obese children.In Vitro and In Vivo Effects of Metformin on Osteopontin Expression in Mice Adipose-Derived Multipotent Stromal Cells and Adipose Tissue Pediatric obesity: etiology and treatment.Analysis of variants and mutations in the human winged helix FOXA3 gene and associations with metabolic traits Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study.Assessment of metformin as an additional treatment to therapeutic lifestyle changes in pediatric patients with metabolic syndrome Pressure To Be Thin and Insulin Sensitivity Among Adolescents Metformin and its clinical use: new insights for an old drug in clinical practice.Pharmacotherapy for childhood obesity: present and future prospects.Predictors of weight-loss response with glucagon-like peptide-1 receptor agonist treatment among adolescents with severe obesity Hyperglycemia-Mediated Oxidative Stress Increases Pulmonary Vascular Permeability.Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative.Exenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot study.Evaluation of differential effects of metformin treatment in obese children according to pubertal stage and genetic variations: study protocol for a randomized controlled trial A longitudinal study of serum insulin and insulin resistance as predictors of weight and body fat gain in African American and Caucasian children.Effects of SLC22A1 Polymorphisms on Metformin-Induced Reductions in Adiposity and Metformin Pharmacokinetics in Obese Children With Insulin Resistance.Childhood obesity for pediatric gastroenterologists.Assessment and management of obesity in childhood and adolescence.The clinical treatment of childhood obesity.Treatment of obesity-related hypertension in children and adolescents.Treatment strategies to prevent renal damage in hypertensive children.Pharmacological management of obesity in pediatric patients.Pharmacotherapy in the Management of Pediatric Obesity.Pediatric obesity pharmacotherapy: current state of the field, review of the literature and clinical trial considerations.Metabolic syndrome in children and adolescents: Old concepts in a young population.Assessment and management of severely obese children and adolescents.An Integrative Analysis of the Effect of Lifestyle and Pharmacological Interventions on Glucose Metabolism in the Prevention and Treatment of Youth-Onset Type 2 Diabetes.Effect of phentermine on weight reduction in a pediatric weight management clinic.Clinical Pharmacokinetics and Pharmacodynamics of Antihyperglycemic Medications in Children and Adolescents with Type 2 Diabetes Mellitus.Effect of folic acid and metformin on insulin resistance and inflammatory factors of obese children and adolescents.Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.

P2860

Q28279770-CA9585C7-28D5-4BE1-81DF-BCD47A7B63EC Q28480735-EB236C7B-B05F-41EE-BFBA-BFB59AF4BCCD Q30413605-2211ECF8-7AEB-4BE0-9858-E7C3CA22C1D6 Q33575907-DB387840-36AF-4EAB-85DF-34975373A951 Q33628264-7F823EA5-A4BD-446C-903B-72DD9310087F Q33749648-4502014B-DB5F-4BB0-830E-7E75E821904E Q33998049-494264DC-86E1-49ED-9853-D9533550D79B Q34028763-0731519B-3EF1-4618-BCA3-C11247A58B66 Q35110509-53576A78-6919-4B85-B4DD-A1F7EE644684 Q35171164-964EA2CD-0E4A-4D95-A3CF-FE48928F88D0 Q35603472-3CE8E7E9-4A63-458B-934D-C14D113ACBCA Q35678445-B86F8CC6-EF8E-4B7E-86A7-BE6C68F19371 Q35716579-C53D1291-C96A-4A61-B536-AA7BE5067157 Q35841253-820477FF-D13E-4198-944A-112554C2000D Q36099847-FB5D213B-672C-45E2-9345-56DD1E12ACF0 Q36409654-ED39827A-E863-4178-964A-14297ABDB7D8 Q36423076-025612D4-B804-41C6-A330-28182972293A Q36468087-DB0C915B-78FB-4CE4-B5DE-7681D61C0088 Q36485989-BEA65F0D-9658-4F29-94DB-98B865B30928 Q36759153-2262715A-36F4-43D2-9DCA-265CE90E6060 Q36794283-86837E49-BF3B-483E-B19E-D949CDA39F78 Q36934365-8567C28E-1CB0-4140-AF8B-3F0CC5E7F2A6 Q37106506-8D530AED-E694-4105-904D-A6A359FB7C1C Q37553110-1C1D1BEB-2BD5-4436-94AB-FAC1E6392DA9 Q37583856-83386815-563C-456E-A171-A35C4BE4CCA3 Q37688013-38997719-0B51-45E8-A35C-76BEFEF4D141 Q37942290-1D4FBAF7-320F-46A5-92C1-793012C029CD Q38016370-E2F893FD-88CC-41BF-B434-F51004189E69 Q38087932-A41E6966-03EF-4B14-AD55-081F51228B33 Q38187597-057D755F-CE17-4242-9A82-90D819AD7905 Q38264661-00A92B19-48DA-49AD-8F26-8ED993B4A6AD Q38667323-90B7B01D-A93A-4BD9-AB07-CE382687CD91 Q38817489-034114A9-C384-4F2A-B1F1-5A3BF14EE4CD Q38853283-A5F7F733-2156-4F1A-95F9-4BF04099A50B Q38867521-5CA8141A-EE67-441D-82A9-96021B6F1104 Q38886919-0F4BE036-D03F-48E1-9929-9834381CB030 Q38989047-F2F24899-57C3-42DB-B20C-D157F8AA3C5E Q39004656-F203D135-F985-4557-872D-7B93A4670B4C Q40428603-1E4DD17A-556D-4829-8409-17995182DB42 Q41085122-6A7D75F6-9EC5-4E2C-A80D-BE7F1425A341

P2860

Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial

http://www.wikidata.org/entity/Q34527061

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Effects of metformin on body w ...... n: a randomized clinical trial

@ast

Effects of metformin on body w ...... n: a randomized clinical trial

@en

Effects of metformin on body w ...... n: a randomized clinical trial

@nl

type

label

Effects of metformin on body w ...... n: a randomized clinical trial

@ast

Effects of metformin on body w ...... n: a randomized clinical trial

@en

Effects of metformin on body w ...... n: a randomized clinical trial

@nl

prefLabel

Effects of metformin on body w ...... n: a randomized clinical trial

@ast

Effects of metformin on body w ...... n: a randomized clinical trial

@en

Effects of metformin on body w ...... n: a randomized clinical trial

@nl

P1433

Q34527061-14CF8F7A-8C9D-46DC-A542-B35D07B686E1

P1476

Q34527061-5D7B4F77-C944-4EA1-925F-9774FA9F672E

P2093

Q34527061-1192DC2B-21B7-4626-8037-DF1537198A7D

Q34527061-225C6AE0-06BE-4967-89CC-2F4D89654D1A

Q34527061-B3FE41F9-E57C-447C-9EDD-0049BC358353

Q34527061-B9FF8B77-E5EC-4EB7-831C-CEFC15AED3CF

Q34527061-C667D992-3545-45E3-BE4A-FB1B8F190FDB

Q34527061-D9D7E4EB-9EF6-4EF7-8117-DAE041CBDBEF

Q34527061-F491FFCF-89FE-4249-89AD-EF1197B799E4

Q34527061-F66FC434-FB66-4D74-8FC9-5ADA694B2F96

P2860

Q34527061-02B10036-013B-4F1C-BA7F-567B5F9D27AC

Q34527061-060DD0F4-A8D2-43F0-BA78-8ABB2AB75B65

Q34527061-2C636556-1681-4E66-ABBB-0342C83D80A0

Q34527061-2F6F7814-32AE-4505-91BC-0D20B440ECD3

Q34527061-30C97C99-63E5-419B-A983-82EE89ECE483

Q34527061-35769F6F-7A30-4688-B302-A7785CCC21C2

Q34527061-3F055F31-58A6-479A-8EA5-1BC785854BA6

Q34527061-4F1FF3FF-2827-4156-8604-66E5B0BD42E0

Q34527061-52BFC66A-EDDF-4EC0-9D87-BB87B296B39F

Q34527061-64A615C0-BA03-4CB7-AE30-8C568714B70A

P304

Q34527061-E3D7D5CD-9F72-425E-B366-6B910E32B381

P31

Q34527061-B36FE549-A7EE-48A9-99C3-FCB41891121A

P356

Q34527061-2E4DD02A-4E1E-4B65-98E5-AFDE739A74EF

P407

Q34527061-2F42CA51-EB88-4393-BEC1-A268C39BB15E

P433

Q34527061-EDA5CA61-24A6-4D42-A7D4-C02A347F5CA3

P478

Q34527061-F79034C5-BAFF-408F-8F6B-D63857F3CE7A

P50

Q34527061-6CA76303-8AFE-4AE6-94D6-8735A154B79C

P577

Q34527061-2020EAF9-4749-4F26-B5D1-3806F632E445

P5875

Q34527061-E57D89E2-18B5-49CD-A6C0-CD0BA6577710

P698

Q34527061-B09A98B2-AFA3-4FCE-97BC-99649B5BA748

P921

Q34527061-3E96E6CD-4F44-4962-BEFB-1BCC730F91B3

Q34527061-74AD7F8B-284C-44CC-A02B-EF829E6E8E92

Q34527061-9E2AFFF8-F39E-499D-8DAE-F1162A940231

P932

Q34527061-BD6B8700-D70F-4068-8FAD-267BD658D0D8

P356

P1433

P1476

Effects of metformin on body w ...... n: a randomized clinical trial

@en

P2093

Christine G Salaita

http://www.w3.org/2001/XMLSchema#string

James C Reynolds

http://www.w3.org/2001/XMLSchema#string

Jennifer R McDuffie

http://www.w3.org/2001/XMLSchema#string

Jonathan Krakoff

http://www.w3.org/2001/XMLSchema#string

Karim A Calis

http://www.w3.org/2001/XMLSchema#string

Merel Kozlosky

http://www.w3.org/2001/XMLSchema#string

Nancy G Sebring

http://www.w3.org/2001/XMLSchema#string

Sheila M Brady

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin Treatment to Prevent Early Puberty in Girls with Precocious Pubarche

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Risk Factors of Vitamin B12 Deficiency in Patients Receiving Metformin

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.

Family-based treatment of severe pediatric obesity: randomized, controlled trial

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.

Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children

Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala.

Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up.

P304

477-485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB10-1185

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Jack A Yanovski

P577

2011-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49749001

http://www.w3.org/2001/XMLSchema#string

P698

21228310

http://www.w3.org/2001/XMLSchema#string

P921

P932

3028347

http://www.w3.org/2001/XMLSchema#string